Clinical Study

Evaluation of Efficacy, Safety, and Cognitive Profile of Amisulpride Per Se and Its Comparison with Olanzapine in Newly Diagnosed Schizophrenic Patients in an 8-Week, Double-Blind, Single-Centre, Prospective Clinical Trial

Table 4

Mean change in PANSS score during study period (scores presented as mean [SD] values).

AmisulprideOlanzapine

PANSS scale
 Total score−16.34 [3.31]−18.31 [5.71]
 Positive score−6.47 [1.68]−7.89 [2.67]
 Negative score−2.25 [0.880]−2.61 [1.14]
 General psychopathology− 7.72 [1.91]−7.71 [2.89]